Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.


Evaluation of the Efficacy and Safety of Inhaled Epoprostenol and Inhaled Nitric Oxide for Refractory Hypoxemia in Patients With Coronavirus Disease 2019

From Critical Care Explorations

In this study, the authors evaluated the efficacy and safety of inhaled epoprostenol and inhaled nitric oxide in patients with refractory hypoxemia secondary to coronavirus disease 2019.

Authors:

DeGrado JR, Szumita, PM, Schuler BR, et al. 


Estimated Time: 25:58

Categories: Quality and Patient Safety, Disaster, Pulmonary,
Content Type: Articles,